Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 in Orct3/Slc22a3-Deficient Mice

REFERENCES

• Amara, S. G., and M. J. Kuhar. 1993. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16:73–93.
   PubMed Web of Science ®Google Scholar
• Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107:303–314.
   PubMedGoogle Scholar
• Bengel, D., D. L. Murphy, A. M. Andrews, C. H. Wichems, D. Feltner, A. Heils, R. Mossner, H. Westphal, and K. P. Lesch. 1998. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice. Mol. Pharmacol. 53:649–655.
   PubMed Web of Science ®Google Scholar
• Breidert, T., F. Spitzenberger, D. Grundemann, and E. Schomig. 1998. Catecholamine transport by the organic cation transporter type 1 (OCT1). Br. J. Pharmacol. 125:218–224.
   PubMed Web of Science ®Google Scholar
• Bzoskie, I., I. Blount, K. Kashiwai, J. Humme, and J. F. Padbury. 1997. Placental norepinephrine transporter development in the ovine fetus. Placenta 18:65–70.
   PubMedGoogle Scholar
• Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991–1995.
   PubMed Web of Science ®Google Scholar
• Dynarowicz, I., T. Trapkowski, and T. Pirus. 1993. Uptake-1, Uptake-2 and the release of [3H]-noradrenaline in uterine artery of pigs during the oestrous cycle. Arch. Vet. Pol. 33:259–267.
   PubMedGoogle Scholar
• Eisenhofer, G., R. McCarty, K. Pacak, H. Russ, and E. Schomig. 1996. Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:287–294.
   Google Scholar
• Fassler, R., and M. Meyer. 1995. Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev. 9:1896–1908.
   PubMed Web of Science ®Google Scholar
• Feldman, R. S., J. S. Meyer, and L. F. Quenzer. 1997. Principles of neuropsychopharmacology. Sinauer Associates Inc., Sunderland, Mass
   Google Scholar
• Friedgen, B., R. Wolfel, H. Russ, E. Schomig, and K. H. Graefe. 1996. The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:275–286.
   Google Scholar
• Fuller, R. W., and S. K. Hemrick-Luecke. 1986. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. Life Sci. 39:1645–1650.
   PubMedGoogle Scholar
• Fuller, R. W., S. K. Hemrick-Luecke, and D. W. Robertson. 1988. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine. Biochem. Pharmacol. 37:3343–3347.
   PubMedGoogle Scholar
• Giros, B., M. Jaber, S. R. Jones, R. M. Wightman, and M. G. Caron. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612.
   PubMed Web of Science ®Google Scholar
• Grundemann, D., J. Babin-Ebell, F. Martel, N. Ording, A. Schmidt, and E. Schomig. 1997. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J. Biol. Chem. 272:10408–10413.
   PubMed Web of Science ®Google Scholar
• Grundemann, D., S. Koster, N. Kiefer, T. Breidert, M. Engelhardt, F. Spitzenberger, N. Obermuller, and E. Schomig. 1998. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J. Biol. Chem. 273:30915–30920.
   PubMed Web of Science ®Google Scholar
• Grundemann, D., G. Liebich, N. Kiefer, S. Koster, and E. Schomig. 1999. Selective substrates for non-neuronal monoamine transporters. Mol. Pharmacol. 56:1–10.
   PubMed Web of Science ®Google Scholar
• Grundemann, D., B. Schechinger, G. A. Rappold, and E. Schomig. 1998. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat. Neurosci. 1:349–351.
   PubMed Web of Science ®Google Scholar
• Iversen, L. L.. 1965. The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. Br. J. Pharmacol. 25:18–33.
   Web of Science ®Google Scholar
• Kujacic, M., and A. Carlsson. 1994. Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:245–251.
   Google Scholar
• Mooslehner, K. A., and N. D. Allen. 1999. Cloning of the mouse organic cation transporter 2 gene, Slc22a2, from an enhancer-trap transgene integration locus. Mamm. Genome 10:218–224.
   PubMed Web of Science ®Google Scholar
• Russ, H., M. Gliese, J. Sonna, and E. Schomig. 1992. The extraneuronal transport mechanism for noradrenaline (Uptake-2) avidly transports 1-methyl-4-phenylpyridinium (MPP+). Naunyn-Schmiedeberg's Arch. Pharmacol. 346:158–165.
   Google Scholar
• Russ, H., J. Sonna, K. Keppler, S. Baunach, and E. Schomig. 1993. Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:458–465.
   Google Scholar
• Russ, H., K. Staust, F. Martel, M. Gliese, and E. Schomig. 1996. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur. J. Neurosci. 8:1256–1264.
   PubMed Web of Science ®Google Scholar
• Sayre, L. M.. 1989. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol. Lett. 48:121–149.
   PubMedGoogle Scholar
• Schomig, E., and C. L. Schonfeld. 1990. Extraneuronal noradrenaline transport (Uptake-2) in a human cell line (Caki-1 cells). Naunyn-Schmiedeberg's Arch. Pharmacol. 341:404–410.
   Google Scholar
• Schweifer, N., and D. P. Barlow. 1996. The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters. Mamm. Genome 7:735–740.
   PubMed Web of Science ®Google Scholar
• Shannon, J. R., N. L. Flattem, J. Jordan, G. Jacob, B. K. Black, I. Biaggioni, R. D. Blakely, and D. Robertson. 2000. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N. Engl. J. Med. 342:541–549.
   PubMed Web of Science ®Google Scholar
• Snijder, S. H., R. J. D'Amato, J. S. Nye, and J. A. Javitch. 1986. Selective uptake of MPP+ by dopamine neurons is required for MPTP neurotoxicity: studies in brain synaptosomes and PC-12 cells. MPTP: a neurotoxin producing a Parkinsonian syndrome.. S. P. Markey, N. Castagnoli, A. J. Trevor, and I. J. Kopin. 191–201. Academic Press, Inc., Orlando, Fla
   Google Scholar
• Stein, H., K. Oyama, A. Martinez, B. Chappell, and J. Padbury. 1993. Plasma epinephrine appearance and clearance rates in fetal and newborn sheep. Am. J. Physiol. 265:R756–R760.
   PubMedGoogle Scholar
• Streich, S., M. Bruss, and H. Bonisch. 1996. Expression of the extraneuronal monoamine transporter (Uptake-2) in human glioma cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:328–333.
   Google Scholar
• Thomas, S. A., A. M. Matsumoto, and R. D. Palmiter. 1995. Noradrenaline is essential for mouse fetal development. Nature 374:643–646.
   PubMed Web of Science ®Google Scholar
• Trendelenburg, U.. 1988. The extraneuronal uptake and metabolism of catecholamines. Handb. Exp. Pharmacol. 90/I:279–319.
   Google Scholar
• Verhaagh, S., D. P. Barlow, and R. Zwart. 2001. The extraneuronal monoamine transporter Slc22a3/Orct3 co-localizes with the Maoa metabolizing enzyme in mouse placenta. Mech. Dev. 100:127–130.
   PubMedGoogle Scholar
• Verhaagh, S., N. Schweifer, D. P. Barlow, and R. Zwart. 1999. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26–q27. Genomics 55:209–218.
   PubMed Web of Science ®Google Scholar
• Wu, X., R. Kekuda, W. Huang, Y. J. Fei, F. H. Leibach, J. Chen, S. J. Conway, and V. Ganapathy. 1998. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (Uptake-2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273:32776–32786.
   PubMed Web of Science ®Google Scholar
• Xu, F., R. R. Gainetdinov, W. C. Wetsel, S. R. Jones, L. M. Bohn, G. W. Miller, Y. M. Wang, and M. G. Caron. 2000. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3:465–471.
   PubMed Web of Science ®Google Scholar
• Zwart, R., S. Verhaagh, J. de Jong, M. Lyon, and D. P. Barlow. Genetic analysis of the organic cation transporter genesOrct2/Slc22a2 and Orct3Slc22a3 reduces the critical region for the t haplotype mutanttw73 to 200 kb. Mammal. Genome, in press.
   Google Scholar